Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director departure

Turning Point Therapeutics, Inc. (TPTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/29/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
08/23/2022 EFFECT Form EFFECT - Notice of Effectiveness:
08/17/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/17/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/17/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/17/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/17/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/17/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/17/2022 8-K Quarterly results
08/16/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
08/16/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/09/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
08/09/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/08/2022 8-K Quarterly results
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/19/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
07/19/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
07/01/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
07/01/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/24/2022 8-K Quarterly results
06/21/2022 8-K Quarterly results
06/17/2022 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
06/17/2022 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
06/03/2022 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
06/03/2022 8-K Quarterly results
06/03/2022 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
06/03/2022 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
06/03/2022 8-K Quarterly results
05/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/10/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
04/29/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/29/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/13/2022 8-K Investor presentation
Docs: "ADVANCED SOLID TUMORS EXP-1 ROS1"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy